Stockscreener 앱 받기
12.02
0.08%
0.010
시간 외 거래:
12.11
0.09
+0.75%
전일 마감가:
$12.01
열려 있는:
$12.02
하루 거래량:
3.39M
Relative Volume:
0.77
시가총액:
$5.94B
수익:
$4.45B
순이익/손실:
$205.00M
주가수익비율:
30.05
EPS:
0.4
순현금흐름:
$372.00M
1주 성능:
+5.16%
1개월 성능:
-2.36%
6개월 성능:
-7.89%
1년 성능:
-18.78%
1일 변동 폭
$11.97
$12.19
1주일 범위
$11.17
$12.19
52주 변동 폭
$11.11
$18.80
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
2500 INNOVATION WAY, GREENFIELD
ELAN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
12.02 | 5.94B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
165.89 | 74.84B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
12.92 | 40.96B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.92 | 24.83B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
143.26 | 14.50B | 2.24B | 385.90M | 440.10M | 3.73 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
2025-01-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
ELAN (Elanco Animal Health) Deferred Tax : $0 Mil (TTM As of Sep. 2024) - GuruFocus.com
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Elanco Animal Health's SWOT analysis: stock outlook amid product challenges - MSN
ELAN (Elanco Animal Health) Long-Term Debt : $4,313 Mil (As of Sep. 2024) - GuruFocus.com
Elanco Animal Health’s SWOT analysis: stock outlook amid product challenges - Investing.com Nigeria
Companion Animal Ear Infection Treatment Market SWOT Analysis by Leading Expert: Elanco, Vetoquinol, Ceva - openPR
2025-01-15 | Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
Veterinary Vaccines Market SWOT Analysis by Leading Expert: Virbac, Elanco, HIPRA - openPR
ELAN (Elanco Animal Health) Change In Working Capital : $239 Mil (TTM As of Sep. 2024) - GuruFocus.com
2025-01-12 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect | NYSE:ELAN | Press Release - Stockhouse Publishing
Is Elanco Animal Health (ELAN) the Best Medical Stock to Buy Under $20? - Insider Monkey
12 Best Medical Stocks To Buy Under $20 - Insider Monkey
Elanco Animal Health Incorporated (NYSE:ELAN) Stock Position Increased by Harbor Capital Advisors Inc. - MarketBeat
Elanco Animal Health (FRA:5EA) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Jan. 10, 2025) - GuruFocus.com
Elanco Animal Health (FRA:5EA) Gross Profit : €2,236 Mil (TTM As of Sep. 2024) - GuruFocus.com
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of “Hold” from Analysts - Defense World
Animal Health Business Research Report 2024-2030 Featuring Major PlayersBayer, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Heska, Merck, Nutreco, Vetiquinol, Virbac, and Zoetis - Yahoo Finance
17,250 Shares in Elanco Animal Health Incorporated (NYSE:ELAN) Purchased by Everence Capital Management Inc. - Defense World
Elanco Animal Health (NYSE:ELAN) Reaches New 52-Week Low on Analyst Downgrade - Defense World
Elanco Animal Health (FRA:5EA) Other Long Term Assets : €272 Mil (As of Sep. 2024) - GuruFocus.com
Douglas Lane & Associates LLC Trims Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Growth Trends in the Porcine Vaccines Market, Forecast to 2028: Increasing Government Initiatives for Funding Animal Husbandry - GlobeNewswire Inc.
Elanco Animal Health (NYSE:ELAN) Sets New 1-Year Low on Analyst Downgrade - MarketBeat
2025-01-08 | Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
Elanco Animal Health (NYSE:ELAN) Takes On Some Risk With Its Use Of Debt - Simply Wall St
Versant Capital Management Inc Sells 1,241 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Stifel Nicolaus Lowers Elanco Animal Health (NYSE:ELAN) Price Target to $18.00 - MarketBeat
Veterinary Oncology Market Generated Opportunities, Future - openPR
Principal Financial Group Inc. Sells 21,919 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
2025-01-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
JPMorgan Chase & Co. Increases Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Animal Hormones Market Forecast: Size, Share, Growth, Key - openPR
Elanco Animal Health (NYSE:ELAN) investors are sitting on a loss of 60% if they invested five years ago - Yahoo Finance
Franklin Resources Inc. Acquires 45,795 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.12%
0.94%
자본화:
|
볼륨(24시간):